1296 related articles for article (PubMed ID: 18558303)
21. Biochemical effects of calcium and vitamin D supplementation in elderly, institutionalized, vitamin D-deficient patients.
Chapuy MC; Chapuy P; Thomas JL; Hazard MC; Meunier PJ
Rev Rhum Engl Ed; 1996 Feb; 63(2):135-40. PubMed ID: 8689285
[TBL] [Abstract][Full Text] [Related]
22. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients.
Tokmak F; Quack I; Schieren G; Sellin L; Rattensperger D; Holland-Letz T; Weiner SM; Rump LC
Nephrol Dial Transplant; 2008 Dec; 23(12):4016-20. PubMed ID: 18593741
[TBL] [Abstract][Full Text] [Related]
23. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
Greenbaum LA; Benador N; Goldstein SL; Paredes A; Melnick JZ; Mattingly S; Amdahl M; Williams LA; Salusky IB
Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
[TBL] [Abstract][Full Text] [Related]
24. Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis.
Boas SR; Hageman JR; Ho LT; Liveris M
J Cyst Fibros; 2009 Jul; 8(4):270-2. PubMed ID: 19447079
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D deficiency and insufficiency in patients with chronic kidney disease.
Diniz HF; Romão MF; Elias RM; Romão Júnior JE
J Bras Nefrol; 2012 Mar; 34(1):58-63. PubMed ID: 22441183
[TBL] [Abstract][Full Text] [Related]
26. Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.
Glendenning P; Chew GT; Inderjeeth CA; Taranto M; Fraser WD
Bone; 2013 Oct; 56(2):271-5. PubMed ID: 23792937
[TBL] [Abstract][Full Text] [Related]
27. Real-world doxercalciferol treatment in SHPT CKD stage 3 and 4: an analysis of change in iPTH and accordance to KDOQI recommendations.
Kumar N; Lindberg J; David K; Morris J; Menoyo J
Am J Nephrol; 2009; 29(2):71-8. PubMed ID: 18689981
[TBL] [Abstract][Full Text] [Related]
28. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients.
Shah N; Bernardini J; Piraino B
Perit Dial Int; 2005; 25(4):362-6. PubMed ID: 16022093
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and biological consequences of vitamin D deficiency in elderly institutionalized subjects.
Fardellone P; Sebert JL; Garabedian M; Bellony R; Maamer M; Agbomson F; Brazier M
Rev Rhum Engl Ed; 1995 Oct; 62(9):576-81. PubMed ID: 8574630
[TBL] [Abstract][Full Text] [Related]
31. Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index.
Lee P; Greenfield JR; Seibel MJ; Eisman JA; Center JR
Am J Med; 2009 Nov; 122(11):1056-60. PubMed ID: 19854337
[TBL] [Abstract][Full Text] [Related]
32. Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial.
Moreira-Pfrimer LD; Pedrosa MA; Teixeira L; Lazaretti-Castro M
Ann Nutr Metab; 2009; 54(4):291-300. PubMed ID: 19729890
[TBL] [Abstract][Full Text] [Related]
33. Prescription ergocalciferol dosing for vitamin D repletion: a retrospective evaluation.
Vande Griend JP; McQueen RB; Linnebur SA; Vondracek SF
Pharmacotherapy; 2012 Feb; 32(2):135-41. PubMed ID: 22392422
[TBL] [Abstract][Full Text] [Related]
34. [Review of the concept of vitamin D "sufficiency and insufficiency"].
Gómez Alonso C; Naves Díaz M; Rodríguez García M; Fernández Martín JL; Cannata Andía JB
Nefrologia; 2003; 23 Suppl 2():73-7. PubMed ID: 12778859
[TBL] [Abstract][Full Text] [Related]
35. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of 25(OH) vitamin D (calcidiol) deficiency at time of renal transplantation: a prospective study.
Sadlier DM; Magee CC
Clin Transplant; 2007; 21(6):683-8. PubMed ID: 17988259
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of vitamin D inadequacy in Belfast following fragility fracture.
Beringer T; Heyburn G; Finch M; McNally C; McQuilken M; Duncan M; Dixon T
Curr Med Res Opin; 2006 Jan; 22(1):101-5. PubMed ID: 16393436
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.
Hiremath GS; Cettomai D; Baynes M; Ratchford JN; Newsome S; Harrison D; Kerr D; Greenberg BM; Calabresi PA
Mult Scler; 2009 Jun; 15(6):735-40. PubMed ID: 19383644
[TBL] [Abstract][Full Text] [Related]
39. Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial.
Kovesdy CP; Lu JL; Malakauskas SM; Andress DL; Kalantar-Zadeh K; Ahmadzadeh S
Am J Kidney Dis; 2012 Jan; 59(1):58-66. PubMed ID: 21885174
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of vitamin D inadequacy in osteoporotic hip fracture patients in London.
Moniz C; Dew T; Dixon T
Curr Med Res Opin; 2005 Dec; 21(12):1891-4. PubMed ID: 16368037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
